Method for Diagnosing Scleroderma

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20150185226A1
SERIAL NO

14416334

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to an in vitro method for diagnosing scleroderma in a subject, said method comprising the step of detecting in a biological sample obtained from the subject one or more autoantibodies recognizing one or more protein biomarkers selected from the group of proteins consisting of THEX1, AIF1, FGF2, EphB2, CLK1 and ANKS6.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)101 RUE DE TOLBIAC PARIS CEDEX 13 75654
UNIVERSITE D'AIX-MARSEILLE13007 MARSEILLE
ASSISTANCE PUBLIQUE-HOPITAUX DE MARSEILLE80 RUE BROCHIER MARSEILLE F-13005

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Auger, Isabelle Marseille Cedex 09, FR 7 11
Lambert, Nathalie Marseille Cedex 09, FR 3 2
Roudier, Jean Marseille Cedex 09, FR 8 11

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation